News
Nguyen Thi Thanh visited the Ho Chi Minh Space, as well as the Thang Long Imperial Citadel and Co Loa Heritage Exhibition in ...
Nguyen Thi Thanh attended the 50th session of the Francophone Parliamentary Assembly (APF-50) convened in Paris from July 9-13, reaffirming Vietnam’s active and constructive role within the ...
Aligned with its strategy to strengthen local industrial capabilities, Thales will partner with Malaysian enterprise Weststar Group to install and deploy the radars in line with the terrain and ...
4d
GlobalData on MSNThales to deliver two GM400α radars to Malaysian Air ForceThe Royal Malaysian Air Force (RMAF) has awarded Thales a contract to supply two more Ground Master 400 alpha (GM400α) radars.
A Letter of Award (LoA) was also issued but the project was stalled ... Bureaucratic inertia and shifting priorities have left the area undeveloped. Naveen Manglani, vice-president of Chamber of ...
France Friendship Parliamentarians Group led by its Chairwoman Nguyen Thuy Anh paid a working visit to France from July 6 to ...
2d
GlobalData on MSNIGI and AbbVie sign licence deal for cancer and autoimmune therapyIGI Therapeutics has signed an exclusive licensing agreement with AbbVie, for ISB 2001 to treat cancer and autoimmune diseases.
5d
Pharmaceutical Technology on MSNGSK acquires efimosfermin alfa from Boston Pharma for $2bnGSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease, from Boston Pharmaceuticals ...
3d
Clinical Trials Arena on MSNLEO Pharma reports results from interim analysis of Phase IIIb atopic dermatitis trialLEO Pharma has reported outcomes from the 16-week interim analysis of the Phase IIIb ADHAND trial of tralokinumab for hand atopic dermatitis (AD).
4d
Clinical Trials Arena on MSNUroGen concludes enrolment in Phase III trial of UGN-103 for bladder cancerUroGen Pharma has completed the enrolment of subjects in its Phase III UTOPIA trial, which is evaluating UGN-103 for intravesical solution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results